|
CUMYL-PICA (SGT-56) is an indole-3-carboxamide based synthetic cannabinoid. It is the α,α-dimethylbenzyl analogue of SDB-006.〔(【引用サイトリンク】 title=CUMYL-PICA )〕 It was briefly sold in New Zealand during 2013 as an ingredient of at the time legal synthetic cannabis products, but the product containing CUMYL-BICA and CUMYL-PICA was denied an interim licensing approval under the Psychoactive Substances regulatory scheme, due to reports of adverse events in consumers.〔(The Risk Assessment Score Table. New Zealand Ministry of Health, 27 September 2013 )〕 CUMYL-PICA acts as a potent agonist for the cannabinoid receptors, with approximately 20x selectivity for CB1, having an EC50 of 0.66nM for human CB1 receptors and 13nM for human CB2 receptors. ==See also== * 5F-CUMYL-PINACA * 5F-SDB-006 * CUMYL-PINACA * CUMYL-THPINACA * SDB-006 * NNE1 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「CUMYL-PICA」の詳細全文を読む スポンサード リンク
|